chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Exhausion; back ache; lightheaded; injection site pain; This is a spontaneous report from a contactable consumer or other non health care professional (patient himself). A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EM9809), via an unspecified route of administration , administered in right deltoid on 05Feb2021 08:45 (at the age of 65-years-old) as a unknown dose, number, single for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing, high cholesterol from an unknown date and unknown if ongoing. Concomitant medications included received within 2 weeks valsartan taken for an unspecified indication, start and stop date were not reported; furosemide taken for an unspecified indication, start and stop date were not reported; rosuvastatin taken for an unspecified indication, start and stop date were not reported; aspirin [acetylsalicylic acid] (ASPIRIN) taken for an unspecified indication, start and stop date were not reported; amlodipine besilate (CCB) taken for an unspecified indication, start and stop date were not reported. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No other vaccines within 4 weeks prior to the COVID vaccine. On 06Feb2021, the patient experienced exhausion, back ache, lightheaded, injection site pain. The patient did not receive any treatment for the adverse event. Seriousness of the case reported as No. The outcome of events was not recovered.  Follow-up attempts completed. No further information expected.
Patient called stating 1 1/2 hrs after receiving Adacel and Hep B#1 that her right side hurt. Her back, leg, and arm had  increased pain when sitting.  Otherwise felt ok.  Seemed calm on phone and answered questions without hesitation.   2:45 pm Mother called and stated she went home and her daughter looked pale, "white as a sheet" stated that she continued to hurt and had temperature.  At present she was not having difficulty breathing but did earlier.  PHN advised that she go to dr or ER to be evaluated.
fever of 101; flu like symptoms; chills; headache; This is a spontaneous report received from a contactable consumer, the patient. A 73-year-old female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on the right arm on 19Mar2021 at 11:00 (at the age of 73-years-old) for COVID-19 immunisation. Medical history included blood pressure high (BPH).  The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included terazosin (MANUFACTURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) unspecified route of administration on the right arm on 26Feb2021 at 14:00 as a single dose for COVID-19 immunisation. Additionally, the patient previously took unspecified pill for blood pressure. On 19Mar2021 the body temperature was measured and was found to be 101 (unspecified unit). On 19Mar2021 at 23:00 the patient experienced with fever of 101 unspecified unit, flu like symptoms and at night in bed the patient had chills and headache. Therapeutic measures were taken as a result of events and included treatment with ibuprofen. The clinical outcome of the events fever of 101, flu like symptoms, chills and headache was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Day 10 post vaccine booster i woke up itching like mad all over and within a short amount if time i had hives anywhere i scratched. This continued throughout the next 4 days each one being worse than the day before on day 12 post vaccine i started a. Edrol dose pack that made things much worse and escalated the hives. I spoke to my PCP and was told to switch to zyrtec from the benedryl and to taper off the steroids. Day 15 and 16 i am covered on my entire upper body with hives the itching is insane and i am swollen on my inner thighs and hands and face
CHRONIC ECZEMA ON FOREHEAD, NECK, HANDS, FEET AND CHINS
2 weeks after the patient received the COVID vaccine in her left arm she developed an abscess in her LEFT breast requiring ultrasound and treatment with antibiotics. She started with left breast pain then developed redness and warmth of the breast. She was seen in the office for evaluation then sent for an ultrasound. The ultrasound indicated a 10mmx10mmx8mm abscess. She was then referred to a breast surgeon that day for surgical intervention. The surgeon did not feel that surgical incision and drainage necessary at that time and agreed with the plan to treat initially with antibiotics.
THROAT PAIN; MUSCLE PAIN; FATIGUE; This spontaneous report received from a patient concerned a 53 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included iodine allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042a21a and expiry: 01-MAY-2021) dose was not reported, administered on 01-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-MAY-2021, the subject experienced muscle pain. On 01-MAY-2021, the subject experienced fatigue. On 02-MAY-2021, the subject experienced throat pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fatigue, and muscle pain, and had not recovered from throat pain. This report was non-serious.
Hives - on thighs, belly, lower back, rear of arms.  I've had hives previously and these progressed as I've experienced before.  Treated with OTC antihistamines and aleve for 1 week, then video visit with PCP.  Prescribed Montekulast 1 per day, and hives improved within 24 hours and continually improved until gone as of today April 27 - approx 2 weeks after symptoms started.
Pt c/o redness (2" x 1") to inj site with dime size ecchymosis noted also. Also questionable 'hoarseness" to voice. Pt 2-4 hours later came back home LCTA, min redness to throat, no SOB or other discomfort. 8/5/02 rash gone throat better.
Fever for 5 days getting to over 102.0 degrees F. Rash. Began on day 4 s/p vaccinations.
Moderna 02272021 WAG19209 Moderna 03272021 WAG19209 Moderna 11212021 Booster Drug Emp Flue Shot 12212021 same day as booster both in left arm
3 hours after injection, felt burning. Next am, had swelling and redness approx. 2" diameter which was present for a week.
anxiety with the vaccine; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANXIETY (non-serious), outcome "unknown", described as "anxiety with the vaccine".  Additional information: Reporter stated that the agent mentioned that the caller reported "anxiety with the vaccine" which is a "total misinformation" and slandering as caller did not report any side effect for herself from the vaccine as she did not have any maybe with other patients.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About 5 hours after the shot I experienced cold chills, sweating, and sever body aches
hives; warmth; itching; This case was reported by a consumer via call center representative and described the occurrence of hives in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number 453S4, expiry date 19th March 2022) for prophylaxis.   On 2nd January 2020, the patient received the 1st dose of Shingrix (intramuscular). On 2nd January 2020, less than a day after receiving Shingrix, the patient experienced hives, feeling of warmth and pruritus. The patient was treated with non-drug therapy (Cold Compresses). On an unknown date, the outcome of the hives, feeling of warmth and pruritus were recovering/resolving.   It was unknown if the reporter considered the hives, feeling of warmth and pruritus to be related to Shingrix.  Additional details were received as follows: The patient developed hives on her arm around the injection site.  The hives were in an area about 5 by 5 inches, it was warm to the touch and very itchy.  The patient has spoken to her healthcare professional office about the hives but has not been in to visit. The patient put cold compresses on it to help the symptoms.
received third dose from vial refrigerated for more than 30 days/received third dose and it is unknown if patient is immunocompromised; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received third dose from vial refrigerated for more than 30 days/received third dose and it is unknown if patient is immunocompromised) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received third dose from vial refrigerated for more than 30 days/received third dose and it is unknown if patient is immunocompromised). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received third dose from vial refrigerated for more than 30 days/received third dose and it is unknown if patient is immunocompromised) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.   This case was linked to MOD-2021-358773 (Patient Link).
22 YOF pt with c/o localized erythematous lesion on LUE that she noticed this morning after Varicella vaccine was administered. Vaccine was given on 6-14-20. She also had MMR and Tubersol administered on the same date but on RUE. Pt denies any other symptoms except for chest tightness that she had yesterday that lasted 5 minutes with no other symptoms. She reports the chest discomfort is recurrent and that it occurs once a week or every 2 weeks. She denies discomfort today. She has not been evaluated by a specialist and declined PCP or Cardiology referral today. Pt afebrile. No distress noted. P.E unremarkable except as noted for 4 cm (W)x 3.5 cm (L) erythematous and edematous lesion on LUE. Blanching noted. Atea is warm and tender to touch. No drainage. C/D/I area.
[Covid-19 Vacc Mrna (5-11yr)(pfizer)(pf) 10 Mcg/0.2 Ml Im Susp (orange)] use for COVID-19 under Emergency Use Authorization (EUA): Covid vaccine was not diluted properly resulting in wrong dose of vaccine given to patient.
Patient received 1st dose of Pfizer COVID 19 vaccine. Patient started to feel dizzy and nauseous after the vaccine was administered. Patient did not vomit. Patient stated that she started to feel this way after the shot, however the patient stated that she was very nervous prior to getting the shot and thinks that here feeling nauseous was due to being nervous. After initial dizziness patient improved and had resolution of symptoms with no other issues. Patient provided call back number however it is based in (country). Patient stated that she felt fine and did not need follow up.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included NAPROXEN from 02-Feb-2021 to an unknown date for Migraine, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
4/10/2021   Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, he experienced an adverse reaction with the following symptoms:  dizziness.   Assessment : Time of assessment 0918. Alert and oriented.   Actions taken:  Vitals sign taken  VAERS form obtained and completed by RN.  VS at 0918- BP- 146/81, P- 77, O2- 100%, 0920- BP- 158/89, P- 80, T- 97.9, VS at 0934- 138/81, P- 72       Medications administered: No medication administered.   Disposition: Reports no further symptoms of adverse reaction after observation for 30 minutes. Discharged home. The Patient was provided with Vaccine Information Sheet and instruction to access the system.      Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 4/10/2021  8:33 AM 0.3 mL 12/11/2020 Intramuscular   Manufacturer: Pfizer, Inc   Lot: EW0162
This spontaneous report was received from a nurse who was a friend of a patient's mother and refers to a female patient of unknown age (reported as "in her teens (years)"). The patient's concurrent conditions, pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an unidentified Merck human papillomavirus (HPV) vaccine (name, dose, route and site of administration, lot number and expiration date were not reported) for prophylaxis. On an unknown date, reported as within 6 months after receiving the vaccine, the patient developed severe muscle problems. It was reported that as a result of the severe muscle problems the patient was currently confined to a wheelchair. The outcome of the event was unknown. The relatedness between the event and unspecified Merck HPV was not provided by the reporter. Additionally, a physician who examined the patient on an unknown date attributed the severe muscle problems to the unspecified Merck HPV vaccine. The event was considered as disabling.
Mom states child became "very whiny" and "cried a lot". Also states child became "very reclusive" not interacting with siblings approx 3 days after vaccines.
Mom stated the child had a febrile seizure & went to ER by ambulance was cleared by ER.
I feel a ball on my right arm where the vaccine was put. My right  arm hurts.
Pt was administered SHINGRIX #2 in left deltoid at 9:45 am on Friday, August 18,2018. Pt was observed for 15 minutes post-inoculation. No S/S of adverse reaction were observed. Pt called at about 11:45 am on Monday, August 20, 2018 to state that she had extreme chills and shivering with headache beginning at about 9:00 PM on Friday and continuing through Saturday evening. She reported a peak temperature of 101. Patient states she slept 32 out of 36 hours following the injection. Pt took ADVIL which had no effect. Pt states she feels better as of the morning of Monday, August 20, just fatigued with temperature. Pt states injection site is still sore as of Monday 08/20 am at 11:45.
Headache, nausea, fever, rash, hives, full body ache, neck pain, back pain, weakness (especially in legs).
10/17 deveoped vertigo and advanced in severity on 10/18/11 was unable to walk with out falling due to vertigo also deveoped vomiting. 10/19/11 went to the Emergency Department due to continued symptoms and dehydration given Meclazine and Levequin.  No improvment in symptoms and on 10/24 went to ENT doctor due to vertigo and diagnosed with vestibular neuronitis thought may have been induced by viral infection from Flu Mist. Treated with prednisone, Zofran and Valium. Reported 10/25 to Employee health continued symptoms but some improvement.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 3:16 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021 at 3:16 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was reported as 68.04. Concomitant products were not provided. For Lot no : 035C21A on 27-Oct-2021, excursion time was 9 AM and 10 AM and temperature was 29 and 32 respectively, total doses given for the day was 116, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 29-Sep-2021 and 05-Oct-2021and was moved to clinic on  27-Oct-2021. 6 vials was sent to clinic. Vaccine BUD date was 29-Oct-2021 and 04-Nov-2021. For Lot no : 035C21A vial was stored on cooler 1 , on 27-Oct-2021, Excursion duration At 8 AM: 41, 9 AM: 29, 10 AM: 32, 11 AM: 43, 12 AM: 43, 1PM : 43, 2 PM : 46, 3 PM: 46, 4 PM: 46, 5 PM: 45. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
8 days after vaccination, a rash-type reaction on skin started at injection site; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received first dose of BNT162B2( PFIZER-BIONTECH COVID-19 VACCINE, lot number: Er8734), via an unspecified route of administration, in left arm on 02Apr2021 at 17:00 (at the age of 34-year-old) at single dose for COVID-19 immunization. The patient did not have medical history and did not receive concomitant medications. The patient doesn't have any known allergies to medications, food, or other products and was not pregnant at the time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient hasn't been tested for COVID-19. Eight days after vaccination, the patient experienced a rash-type reaction on skin started at injection site, on 10Apr2021 at 12:00. The patient was not treated for the event. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Locked up my neck and shoulder, still feels like the needles in my arm, flared up my osteoarthritis so bad I thought I needed to have surgery it's still going on till I put two and two together
Severe hot flashes 12 days after first shot/Hot flash on and off for 2 months, after first shot; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Severe hot flashes 12 days after first shot/Hot flash on and off for 2 months, after first shot) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043120A) for COVID-19 vaccination.     The patient's past medical history included Stroke and Hysterectomy.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced HOT FLUSH (Severe hot flashes 12 days after first shot/Hot flash on and off for 2 months, after first shot). On 12-Apr-2021, HOT FLUSH (Severe hot flashes 12 days after first shot/Hot flash on and off for 2 months, after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that On 18-Feb-2022, she no longer has the hot lashes. She was not able to take estrogen because of her medical history of stroke (Many years ago).Last year, her doctor had advised her not to take the second Moderna COVID-19, vaccine because if she had got the hot flashes. Her doctor told her that she needed to start the series again, since it had been a year post first shot. She also knows that the second shot had to be the same brand as the first shot, but since MD told her not to get Moderna second shot, she does not know what to do.  No concomitant medication was reported. No treatment medication was reported.
My entire arm from shoulder to hand became painful, and I was afraid it was a heart attack due to my stents.
(1515) Pt c/o itching to back of throat shortly after receiving vaccine. Pt reported then having some mild chest tightness. Pt reports feeling shaky, anxious. (1520) Pt given BENADRYL 25mg po - pt refused the full 50mg dose. B/P 130/68, RR 20, APR 72. Constant measures given. (1545) 138/74 pt states she is fully better, no chest tightness. (1528) Follow-up call to give report on pt's condition. Pt being observed at flu clinic site. 1600 - pt returned to clinic after sitting back at desk. Reports she feels much better. Took 25mg (2nd dose) of BENADRYL PO. Vital signs stable. 1622 - Spoke with client on phone. Dr. notified of pt's status. Dr. to call pt for any follow-up instructions. 1630 - Pt left flu clinic site without c/o. No s/s respiratory distress noted. Pt denies feeling weak, dizzy.
Pfizer-BioNTech COVID-19 Vaccine EUA Received shot at 11:10 am.   I felt fine all day but at 2am the next morning I woke with a fever, headache and felt terrible.  Fever of 101 degrees lasted all day.  I took Tylenol twice.  Went to bed that night with 100 degree temperature.  Woke next morning with no fever and only a slight headache but am eating now and feel lots better.